Felix Theeuwes
2007
In 2007, Felix Theeuwes earned a total compensation of $1.2M as Chairman and Chief Scientific Officer at DURECT, a 21% increase compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $187,961 |
---|---|
Option Awards | $585,323 |
Salary | $442,260 |
Other | $10,477 |
Total | $1,226,021 |
Theeuwes received $585.3K in option awards, accounting for 48% of the total pay in 2007.
Theeuwes also received $188K in non-equity incentive plan, $442.3K in salary and $10.5K in other compensation.
Rankings
In 2007, Felix Theeuwes' compensation ranked 3,514th out of 8,700 executives tracked by ExecPay. In other words, Theeuwes earned more than 59.6% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 3,514 out of 8,700 | 60th |
Division Manufacturing | 1,251 out of 3,314 | 62nd |
Major group Chemicals And Allied Products | 237 out of 746 | 68th |
Industry group Drugs | 130 out of 546 | 76th |
Industry Pharmaceutical Preparations | 98 out of 364 | 73rd |
Source: SEC filing on April 29, 2010.
Theeuwes' colleagues
We found four more compensation records of executives who worked with Felix Theeuwes at DURECT in 2007.